MRK | tickerfilter.com

Fundamental analysis

55%

Profitability 75%

Dept financing 17%

Liquidity 42%

Performance 49%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-3.22%

1 Month

1.27%

3 Months

18.77%

6 Months

42.57%

1 Year

29.46%

2 Year

-3.40%

Key data

Stock price

$119.83

P/E Ratio

14.31

DAY RANGE

$118.61 - $120.97

EPS

$7.30

52 WEEK RANGE

$73.31 - $125.14

52 WEEK CHANGE

$28.59

MARKET CAP

261.258 B

YIELD

3.12%

SHARES OUTSTANDING

2.472 B

DIVIDEND

$0.85

EX-DIVIDEND DATE

03-16-2026

NEXT EARNINGS DATE

07-29-2025

BETA

0.31

PUBLIC FLOAT

AVERAGE 10 VOLUME

$11,144,130

AVERAGE 30 VOLUME

$13,303,787

Company detail

CEO: Robert M. Davis
Region: US
Website: merck.com
Employees: 69,000
IPO year: 1970

Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Merck & Co. operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services.

MRK - Merck & Co., Inc.